These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9365158)

  • 1. Hypermethylation of the WT1 and calcitonin gene promoter regions at chromosome 11p in human colorectal cancer.
    Hiltunen MO; Koistinaho J; Alhonen L; Myöhänen S; Marin S; Kosma VM; Pääkkönen M; Jänne J
    Br J Cancer; 1997; 76(9):1124-30. PubMed ID: 9365158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation.
    Loeb DM; Evron E; Patel CB; Sharma PM; Niranjan B; Buluwela L; Weitzman SA; Korz D; Sukumar S
    Cancer Res; 2001 Feb; 61(3):921-5. PubMed ID: 11221883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypermethylation of the APC (adenomatous polyposis coli) gene promoter region in human colorectal carcinoma.
    Hiltunen MO; Alhonen L; Koistinaho J; Myöhänen S; Pääkkönen M; Marin S; Kosma VM; Jänne J
    Int J Cancer; 1997 Mar; 70(6):644-8. PubMed ID: 9096643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity at 11p13 in Wilms' tumours does not necessarily involve mutations in the WT1 gene.
    Cowell JK; Groves N; Baird P
    Br J Cancer; 1993 Jun; 67(6):1259-61. PubMed ID: 8390282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.
    Xu XL; Yu J; Zhang HY; Sun MH; Gu J; Du X; Shi DR; Wang P; Yang ZH; Zhu JD
    World J Gastroenterol; 2004 Dec; 10(23):3441-54. PubMed ID: 15526363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermethylation of the Wilms' tumor suppressor gene CpG island in human breast carcinomas.
    Laux DE; Curran EM; Welshons WV; Lubahn DB; Huang TH
    Breast Cancer Res Treat; 1999 Jul; 56(1):35-43. PubMed ID: 10517341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypermethylation of calcitonin gene regulatory sequences in human breast cancer as revealed by genomic sequencing.
    Hakkarainen M; Wahlfors J; Myöhänen S; Hiltunen MO; Eskelinen M; Johansson R; Jänne J
    Int J Cancer; 1996 Dec; 69(6):471-4. PubMed ID: 8980249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of WTAP, a novel Wilms' tumour 1-associating protein.
    Little NA; Hastie ND; Davies RC
    Hum Mol Genet; 2000 Sep; 9(15):2231-9. PubMed ID: 11001926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1.
    Zhang X; Xing G; Saunders GF
    Anticancer Res; 1999; 19(3A):1641-8. PubMed ID: 10470095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter.
    McCoy C; McGee SB; Cornwell MM
    Cell Growth Differ; 1999 Jun; 10(6):377-86. PubMed ID: 10392899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aging and DNA methylation in colorectal mucosa and cancer.
    Ahuja N; Li Q; Mohan AL; Baylin SB; Issa JP
    Cancer Res; 1998 Dec; 58(23):5489-94. PubMed ID: 9850084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrarenal Wilms' tumors. A study of their relationship with classical renal Wilms' tumor using expression of WT1 as a molecular marker.
    Roberts DJ; Haber D; Sklar J; Crum CP
    Lab Invest; 1993 May; 68(5):528-36. PubMed ID: 8388523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human breast and colon cancers exhibit alterations of DNA methylation patterns at several DNA segments on chromosomes 11p and 17p.
    Ribieras S; Song-Wang XG; Martin V; Lointier P; Frappart L; Dante R
    J Cell Biochem; 1994 Sep; 56(1):86-96. PubMed ID: 7806594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overlapping DNA recognition motifs between Sp1 and a novel trans-acting factor within the wt1 tumour suppressor gene promoter.
    Discenza MT; Dehbi M; Pelletier J
    Nucleic Acids Res; 1997 Nov; 25(21):4314-22. PubMed ID: 9336463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. +P5 (D1S3309E), a novel target binding site for the Wilms' tumour suppressor 1 (WT1) gene, maps to human chromosome 1q21-->22.
    Negus K; Holmes GH; Wicking C; Wainwright BJ; Little MH
    Cytogenet Cell Genet; 1996; 72(4):306-9. PubMed ID: 8641136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Wilms' tumor suppressor gene (wt1) product represses different functional classes of transcriptional activation domains.
    Lee TH; Moffett P; Pelletier J
    Nucleic Acids Res; 1999 Jul; 27(14):2889-97. PubMed ID: 10390530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a tumor-specific methylation site in the Wilms tumor suppressor gene.
    Kleymenova EV; Yuan X; LaBate ME; Walker CL
    Oncogene; 1998 Feb; 16(6):713-20. PubMed ID: 9488035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
    Charles AK; Brown KW; Berry PJ
    Am J Pathol; 1998 Sep; 153(3):991-1000. PubMed ID: 9736048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.
    Moelans CB; Verschuur-Maes AH; van Diest PJ
    J Pathol; 2011 Oct; 225(2):222-31. PubMed ID: 21710692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression pattern of Wilms' tumour gene (WT1) product in normal tissues and paediatric renal tumours.
    Ramani P; Cowell JK
    J Pathol; 1996 Jun; 179(2):162-8. PubMed ID: 8758208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.